MS Research Australia is thrilled to be asked to participate in The Sydney Observership Program for the second consecutive year.
The Sydney Observership Program was initially started by Jonathan Gavshon with assistance of well known businessman, David Gonski AC. It provides unique opportunities for young talented individuals, to gain experience on Boards in the not-for-profit sector. All successful candidates are mentored and trained before and throughout their twelve month placement. During that time, Observers attend all Board and Committee meetings as a non-voting member, in order to learn about the fundamental principles and functions of non-profit boards, the role of board members, the processes and other governance priorities.
Last year MS Research Australia’s Board observer was JB Were’s Head of Philanthropic services, Shamal Dass. This year, Fleur Wright, Executive Director at UBS has commenced the program. Fleur has 15 years’ experience collaborating with global banking and investment companies. Under the Program, she has represented MS Research Australia at the inaugural Sohn Hearts and Minds conference and fundraising events for research into Osteogenesis Imperfecta. We believe her experience and knowledge will be extremely beneficial to our organisation.
‘Fleur is an enthusiastic, smart and well-connected young leader. Among other things, we believe she will be a great contribution to our team, particularly in the areas of data analysis, business processes and organisational contacts. We look forward to developing this working relationship throughout the year’ said Chairman, Paul Murnane.
Fleur said ‘The Observership Program has provided me with a robust framework and network to be able to provide support in the not-for-profit sector. I feel particularly lucky to have been paired with MS Research Australia because in my view not only is it a fantastic cause, but a very well run organisation with an experienced Board. I have already witnessed hugely valuable outcomes towards prevention, treatment and a cure for MS’.
Our increasingly diverse Board experience, skill set, tenure and gender balance, are ensuring that we continue to improve and grow our strengths and keep in line with AICD recommendations. Paul also mentioned ‘I am incredibly proud of our transparent processes and the fact that we can provide such an opportunity to a young up and coming professional’.